Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A PHASE 3, PLACEBO CONTROLLED, DOUBLE-BLIND, RANDOMIZED, CLINICAL STUDY TO DETERMINE EFFICACY, SAFETY AND TOLERABILITY OF PULSED, INHALED NITRIC OXIDE (iNO) VERSUS PLACEBO IN SYMPTOMATIC SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) INOvation-1 |
|---|---|
| Full Title | A PHASE 3, PLACEBO CONTROLLED, DOUBLE-BLIND, RANDOMIZED, CLINICAL STUDY TO DETERMINE EFFICACY, SAFETY AND TOLERABILITY OF PULSED, INHALED NITRIC OXIDE (iNO) VERSUS PLACEBO IN SYMPTOMATIC SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) INOvation-1 |
| Disease/Condition | Cardiology |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Ali Zaidi |
| Contact Name | Wolfgang Jorde |
| Contact Email | wjorde@montefiore.org |
| Protocol Number | IRB# 16-02-168-01 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
